Baron & Budd Attorney and Shareholder Burton LeBlanc to Speak on Opioid Epidemic at American Association for Justice
BATON ROUGE, La. – November 17, 2017 – The national law firm of Baron & Budd is pleased to...READ MORE
The chemotherapy drug Taxotere has been blamed for causing alopecia, or permanent hair loss. While this is obviously a disturbing side effect, there are other health problems that have been linked to the drug as well. If you are considering using this medication as part of your fight against cancer, you need to be aware of the potential risks.
Taxotere has been touted as a much more convenient method of chemotherapy treatment than other drugs. While many chemo medications require weekly applications, Taxotere is designed to be taken every three weeks. It works by inhibiting the ability of cancer cells to divide, and as a result, spread to other areas of the body. It is administered intravenously and used to attack many forms of cancer, including head and neck, prostate, breast and non-small cell lung cancer.
Patients across the country are suing Sanofi-Aventis, the manufacturer of Taxotere, claiming the company failed to properly warn them of the risks of taking the drug. They allege they had no idea Taxotere could leave them permanently bald, and would have explored other options if they had known.
But baldness isn’t the only health issue associated with Taxotere. Others include high blood pressure, diarrhea, heart problems, nerve damage, fatigue and an increased risk of infections. A 2012 study that was published in the Journal of Clinical Oncology showed that patients who used Taxotere and similar “new generation” chemo drugs were 52 percent more likely to suffer serious side effects than patients using traditional chemo medications.